Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 4,658 | 4,651 | 6,687 | 6,245 | 5,952 |
| Gross Profit | 4,658 | 4,651 | 6,687 | 6,245 | 5,952 |
| Operating Expenses | 26,216 | 23,036 | 24,100 | 28,807 | 23,763 |
| Operating Income | -21,558 | -18,385 | -17,413 | -22,562 | -17,811 |
| Interest Expense | 46 | 171 | 198 | 309 | 429 |
| Other Income | 1,500 | 1,462 | 1,272 | 939 | 673 |
| Pre-tax Income | -20,104 | -17,094 | -16,339 | -21,932 | -17,567 |
| Net Income Continuous | -20,104 | -17,094 | -16,339 | -21,932 | -17,567 |
| Net Income | $-20,104 | $-17,094 | $-16,339 | $-21,932 | $-17,567 |
| EPS Basic Total Ops | -0.12 | -0.10 | -0.10 | -0.13 | -0.12 |
| EPS Basic Continuous Ops | -0.12 | -0.10 | -0.10 | -0.14 | -0.12 |
| EPS Diluted Total Ops | -0.12 | -0.10 | -0.10 | -0.13 | -0.12 |
| EPS Diluted Continuous Ops | -0.12 | -0.10 | -0.10 | -0.14 | -0.12 |
| EBITDA(a) | $-21,189 | $-18,043 | $-17,079 | $-22,255 | $-17,468 |